Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -3 of 3 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Pharmaceutical / Industry				104-06-301 NCT00617981

Last Modified: 11/21/2008 First Published: 6/22/2006


2.		Phase I Study of Temperature-Sensitive Liposomal Doxorubicin (ThermoDox™) in Combination With Hyperthermia in Women With Locally Recurrent Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				18 and over				NCI				DUMC-6883-06-2R1 DUMC-06068, NCT00346229

Last Modified: 7/18/2007 First Published: 4/13/2007


3.		Phase I Study of Heat-Activated Doxorubicin Hydrochloride Liposome and Radiofrequency Ablation in Patients With Primary or Metastatic Tumors of the Liver

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Treatment				Active				18 and over				NCI, Pharmaceutical / Industry				CELSION-1040610101 104-06-101-01, NCT00441376

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute